Correlation Between DiaMedica Therapeutics and I Mab

Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and I Mab at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and I Mab into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DiaMedica Therapeutics and I Mab, you can compare the effects of market volatilities on DiaMedica Therapeutics and I Mab and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of I Mab. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and I Mab.

Diversification Opportunities for DiaMedica Therapeutics and I Mab

0.04

Correlation Coefficient

DiaMedica Therapeutics  I Mab

Significant diversification

The 3 months correlation between DiaMedica and IMAB is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and I Mab in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on I Mab and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with I Mab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of I Mab has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and I Mab go up and down completely randomly.

Pair Corralation between DiaMedica Therapeutics and I Mab

Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.89 times more return on investment than I Mab. However, DiaMedica Therapeutics is 1.12 times less risky than I Mab. It trades about 0.09 of its potential returns per unit of risk. I Mab is currently generating about 0.04 per unit of risk. If you would invest  215.00  in DiaMedica Therapeutics on July 23, 2024 and sell it today you would earn a total of  219.00  from holding DiaMedica Therapeutics or generate 101.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

DiaMedica Therapeutics  vs.  I Mab

DiaMedica Therapeutics

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

I Mab

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in I Mab are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, I Mab may actually be approaching a critical reversion point that can send shares even higher in November 2024.

Pair Trading with DiaMedica Therapeutics and I Mab

The main advantage of trading using opposite DiaMedica Therapeutics and I Mab positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, I Mab can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in I Mab will offset losses from the drop in I Mab's long position.

The idea behind DiaMedica Therapeutics and I Mab pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.